Liens UNIL

FR EN

Unisciences

You are here: UNIL > Unisciences

Search
- Search
- Show the data
  from to

Centre for Psychiatric Neurosciences

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

1475 publications

... | 2012 | 2011 | 2010 | 2009 | 2008 | ...

2012

Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.

Nikisch Georg, Baumann Pierre, Liu T., Mathé Alexander .A., 2012. International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (cinp), 15 (8) pp. 1051-1061. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_736E83FCC292]

Redox dysregulation affects proliferation, differentiation of oligodendrocyte progenitors and myelination: relevance to dysconnectivity in schizophrenia

Do Kim, 2012. p. 4 dans Biological Psychiatry. Peer-reviewed.

[DOI][serval:BIB_420F0F7D8D6E]

Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC-MS to UPLC-MS/MS.

Noetzli M., Ansermot N., Dobrinas M., Eap C.B., 2012. Journal of Pharmaceutical and Biomedical Analysis, 64-65 pp. 16-25. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_729D59AF62E3]

Simultaneous Optical Recording in Multiple Cells by Digital Holographic Microscopy of Chloride Current Associated to Activation of the Ligand-Gated Chloride Channel GABA(A) Receptor.

Jourdain P., Boss D., Rappaz B., Moratal C., Hernandez M.C., Depeursinge C., Magistretti P.J., Marquet P., 2012. Plos One, 7 (12) pp. e51041. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_8D169A5DD22B]

Simultaneous quantification of selective serotonin reuptake inhibitors and metabolites in human plasma by liquid chromatography-electrospray mass spectrometry for therapeutic drug monitoring.

Ansermot N., Brawand-Amey M., Eap C.B., 2012. Journal of Chromatography. B, Analytical Technologies In the Biomedical and Life Sciences, 885-886 pp. 117-130. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A240259C3DE5]

SPCC TDM , a catalogie for analysis of therapeutic drug monitoring related contents in the drug prescription information

Ulrich Sven, Baumann Pierre, Conca Andreas, Kuss Hans-Joachim, Stieffenhofer V., Hiemke Christoph, 2012. pp. 319-328 dans Li X.-L., Ng S.-K. (eds.) Computational Knowledge Discovery for Bioinformatics Research, IGI-Global.

[serval:BIB_01587A7C5F97]

Sweet sixteen for ANLS.

Pellerin L., Magistretti P.J., 2012. Journal of Cerebral Blood Flow and Metabolism, 32 (7) pp. 1152-1166. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_6AF150415C7E]

TDM in patients with substance related disorders

Havemann-Reinecke U., Bruenen S., Vincent P., Baumann P., Hiemke C., 2012. p. 1 dans 20th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_A1581A386476]

The AGNP-TDM expert group consensus guidelines 2004 -therapeutic drug monitoring in psychiatry: Analysis of 199 citations (2004 - 2011)

Baumann P., Hiemke C., 2012. p. 1 dans 20th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[URN][serval:BIB_040D4E3488FC]

The influence of frontal glutathione levels on white matter connectivity in healthy and early psychosis subjects: a preliminary study

Griffa A., Baumann P.S., Xin L., Crespi S., Ferrari C., Mekle R., Gruetter R., Do K., Conus P., Hagmann P., 2012. dans ESMRMB 2012, 29th Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology.

[URN][serval:BIB_4CE208AA96E4]

The Island of Drive. Representations, somatic states and the origin of drive

Magistretti Pierre J., Ansermet François, 2012. Schweizer Archiv für Neurologie und Psychiatrie = Archives suisses de neurologie et de psychiatrie = Swiss archives of neurology and psychiatry, 164 (8) pp. 281-285. Peer-reviewed.

[serval:BIB_9A5865187637]

The specificity of amyloid imaging in the diagnosis of neurodegenerative diseases.

Frisoni G.B., Giannakopoulos P., 2012. Neurobiology of Aging, 33 (6) pp. 1021-1022. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F47FA0B967EA]

Viktor von Weizsäcker et le national-socialisme [Viktor von Weizsäcker and national socialism].

Baumann P., 2012. Revue Médicale Suisse, 8 (333) pp. 655; discussion 656.

[Pmid][serval:BIB_CE0E5173F4BE]

2011

La pharmacogénétique/pharmacogénomique en psychiatrie, perspectives théoriques et perspectives pour l'avenir

Chanachev Aleksandar, Conus Philippe, Eap Chin Bin, 2011/11. L'information psychiatrique, 87 (9) pp. 697-703.

[URN][serval:BIB_19F9C955F61D]

Syndrome métabolique et antipsychotiques atypiques : recommandations et prise en charge clinique

Solida Alessandra, Choong Eva, Lechaire Catherine, Eap Chin Bin, Conus Philippe, 2011/11. L'information psychiatrique, 87 (9) pp. 715-724.

[serval:BIB_801E95AC0389]

Syndrome métabolique et antipsychotiques atypiques: recommandations et prise en charge clinique

Solida Alexandra, Choong Eva, Eap Chin, 2011/11/01. L’Information psychiatrique, 87 (9) pp. 715-24.

[serval:BIB_38CA59D000DE]

14ème Journée de Recherche des Départements de Psychiatrie de Genève et de Lausanne

Choong E, Conus P, Eap C, Bondolfi G, Von Gunten A, Preisig M, 2011/06/01. dans Clinical and pharmacogenetic studies on response and side-effects under psychotropic drugs.

[serval:BIB_F75FCBF7ED3D]

A new rating scale to evaluate the potential benefit of therapeutic drug monitoring

Bruenen S., Vincent P.D., Baumann P., Hiemke C., Havemann-Reinecke U., 2011. pp. 499-500 dans 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Therapeutic Drug Monitoring. Peer-reviewed.

[DOI][WoS][serval:BIB_3D37BCBBB4E9]

Absence of association between specific common variants of the obesity-related FTO gene and psychological and behavioral eating disorder phenotypes.

Jonassaint C.R., Szatkiewicz J.P., Bulik C.M., Thornton L.M., Bloss C., Berrettini W.H., Kaye W.H., Bergen A.W., Magistretti P., Strober M. et al., 2011. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 156 (4) pp. 454-461. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D6E6CF6AE4C5]

Accurate performance of a rat model of schizophrenia in the water maze depends on visual cue availability and stability: a distortion in cognitive mapping abilities?

Preissmann D., Bertholet L., Sierro G., Cabungcal J.H., Schenk F., 2011. Behavioural Brain Research, 223 (1) pp. 145-153. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0A415FAC603E]

Addition of aripiprazole to the clozapine may be useful in reducing anxiety in treatment-resistant schizophrenia.

Chanachev A., Ansermot N., Crettol Wavre S., Nowotka U., Stamatopoulou M.E., Conus P., Eap C.B., 2011. Case Reports In Psychiatry, 2011 p. 846489. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_70D83905314A]

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

Hiemke C., Baumann P., Bergemann N., Conca A., Dietmaier O., Egberts K., Fric M., Gerlach M., Greiner C., Gründer G. et al., 2011. Pharmacopsychiatry, 44 (6) pp. 195-235. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_DF1A79714744]

Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit; relevance for neuroenergetics in schizophrenia.

Lavoie S., Allaman I., Petit J.M., Do K.Q., Magistretti P.J., 2011. Plos One, 6 (7) pp. e22875. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_5E49D9D3D523]

Altered Local Beta and Gamma Synchronization in Prefrontal Cortex of Mice with Redox Dysregulation or Maternal Immune Activation

Steullet P., Cabungcal J.H., Meyer U., Cuenod M., Do K.Q., 2011. pp. 121S dans 66th Annual Meeting of the Society of Biological Psychiatry, Biological Psychiatry. Peer-reviewed.

[WoS][serval:BIB_546338C2270B]

An exploratory study on facial emotion recognition capacity in beginning Alzheimer's disease.

Wiechetek Ostos M., Schenk F., Baenziger T., von Gunten A., 2011. European Neurology, 65 (6) pp. 361-367. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_1AE0D69592DB]

Association of candidate genes with phenotypic traits relevant to anorexia nervosa.

Root T.L., Szatkiewicz J.P., Jonassaint C.R., Thornton L.M., Pinheiro A.P., Strober M., Bloss C., Berrettini W., Schork N.J., Kaye W.H. et al., 2011. European Eating Disorders Review : the Journal of the Eating Disorders Association, 19 (6) pp. 487-493. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_68AD1095AC59]

Astrocyte-neuron lactate transport is required for long-term memory formation.

Suzuki A., Stern S.A., Bozdagi O., Huntley G.W., Walker R.H., Magistretti P.J., Alberini C.M., 2011. Cell, 144 (5) pp. 810-823. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_C2220047B1FB]

Astrocyte-neuron metabolic relationships: for better and for worse.

Allaman I., Bélanger M., Magistretti P.J., 2011. Trends In Neurosciences, 34 (2) pp. 76-87. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_62211B046E29]

Cytochrome P450 1A2 activity and inducibility: impact of smoking, smoking cessation and genetic polymorphisms

Dobrinas M., Cornuz J., Oneda B., Kohler S.M., Puhl M., Eap C.B., 2011. p. 473 dans 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Therapeutic Drug Monitoring. Peer-reviewed.

[WoS][serval:BIB_651AFCC700D9]

Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study.

Nikisch Georg, Baumann Pierre, Oneda B., Kiessling B., Weisser H., Mathé A.A., Yoshitake T., Kehr J., Wiedemann G., Eap Chin B., 2011. Journal of Psychopharmacology, 25 (7) pp. 896-907. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B7D93AB98992]

Determination of Transmembrane Water Fluxes in Neurons Elicited by Glutamate Ionotropic Receptors and by the Cotransporters KCC2 and NKCC1: A Digital Holographic Microscopy Study.

Jourdain P., Pavillon N., Moratal C., Boss D., Rappaz B., Depeursinge C., Marquet P., Magistretti P.J., 2011. Journal of Neuroscience, 31 (33) pp. 11846-11854. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_66CBCD2B7CBB]

Die schweizerische Gesellschaft für Arzneimittelsicherheit in der Psychiatrie

Baumann Pierre, Angst Katrin, Brunner Sandra, Eich Philipp, Giachino Philipp, Hasler Gregor, Jaquenoud Sirot Eveline, Horvath Andreas, Keck Marin, Schuhmann Thomas et al., 2011. InFo Neurologie und Psychiatrie, 9 (1) p. 43.

[serval:BIB_992136C5A166]

Differential effects of pro- and anti-inflammatory cytokines alone or in combinations on the metabolic profile of astrocytes.

Bélanger M., Allaman I., Magistretti P.J., 2011. Journal of Neurochemistry, 116 (4) pp. 564-576. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DBA12B8DF103]

Dosages plasmatiques de médicaments psychotropes à des fins thérapeutiques et tests pharmacogénétiques

Baumann Pierre, 2011. pp. 71-75 dans Calanca Aldo, Bryois Christian, Buclin Thierry (eds.) Vade-mecum de thérapqutique psychiatrique, Editions Médecine & Hygiène.

[serval:BIB_2DE9C4E31C1D]

Drug interactions in the treatment of Bipolar disorder

Baumann Pierre, 2011. p. 2028 dans 19th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_471FE6DE1191]

Duration of untreated psychosis: a proposition regarding treatment definition.

Polari A., Lavoie S., Sarrasin P., Pellanda V., Cotton S., Conus P., 2011. Early Intervention In Psychiatry, 5 (4) pp. 301-308. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4EF1BFD37055]

Effects of motive-oriented therapeutic relationship in early-phase treatment of borderline personality disorder: a pilot study of a randomized trial.

Kramer U., Berger T., Kolly S., Marquet P., Preisig M., de Roten Y., Despland J.N., Caspar F., 2011. Journal of Nervous and Mental Disease, 199 (4) pp. 244-250. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_3F4B4B6BB76E]

Escitalopram in der klinischen Praxis: eine Erhebung von Praxiserfahrungen bei Patienten mit Depressionen und Angstörungen

Holsboer-Trachsler Edith, Baumann Pierre, Höck Paul, Hättenschwiler Josef, Jost Martin, Ramseier Fritz, Seifritz Erich, Nil Rico, 2011. Psychopharmakotherapie: Arzneimitteltherapie psychischer und neurologischer Erkrankungen, 18 (2) pp. 59-65.

[serval:BIB_9E70D095490C]

Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes.

Allaman I., Fiumelli H., Magistretti P.J., Martin J.L., 2011. Psychopharmacology, 216 (1) pp. 75-84. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_91FBB98B6E45]

Genetic Association of Recovery from Eating Disorders: The Role of GABA Receptor SNPs.

Bloss C.S., Berrettini W., Bergen A.W., Magistretti P., Duvvuri V., Strober M., Brandt H., Crawford S., Crow S., Fichter M.M. et al., 2011. Neuropsychopharmacology, 36 (11) pp. 2222-32. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_BEE86E381580]

Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia.

Gysin R., Kraftsik R., Boulat O., Bovet P., Conus P., Comte-Krieger E., Polari A., Steullet P., Preisig M., Teichmann T. et al., 2011. Antioxidants and Redox Signaling, 15 (7) pp. 2003-2010. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_43FDB52BB2BB]

Glutamate Transport Decreases Mitochondrial pH and Modulates Oxidative Metabolism in Astrocytes.

Azarias G., Perreten H., Lengacher S., Poburko D., Demaurex N., Magistretti P.J., Chatton J.Y., 2011. Journal of Neuroscience, 31 (10) pp. 3550-3559. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_1F0FA45DD911]

Glutathione deficit and redox dysregulation in animal models of schizophrenia

Steullet Pascal, Cabungcal Jan-Harry, Kulak Anita, Cuenod Michel, Schenk Françoise, Do Cuenod Kim, 2011. pp. 149-188 dans O'Donnell Patricio (eds.) Animal models of schizophrenia and related disorders chap. 7, Humana Press/Springer.

[DOI][serval:BIB_7E6209600FC3]

High b-value Diffusion-weighted Imaging: A Sensitive Method to Reveal White Matter Changes in Schizophrenia

Baumann P.S., Cammoun L., Conus P., Do K.Q., Marquet P., Meskaldji D., Meuli R., Thiran J.P., Hagmann P., 2011. pp. 257S dans 66th Annual Meeting of the Society of Biological Psychiatry, Biological Psychiatry. Peer-reviewed.

[WoS][serval:BIB_C271CD4E7870]

Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility.

Dobrinas M., Cornuz J., Oneda B., Kohler Serra M., Puhl M., Eap C.B., 2011. Clinical Pharmacology and Therapeutics, 90 (1) pp. 117-125. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C7A4910B063E]

Interaction of GAG trinucleotide repeat and C-129T polymorphisms impairs expression of the glutamate-cysteine ligase catalytic subunit gene.

Butticaz C., Gysin R., Cuénod M., Do K.Q., 2011. Free Radical Biology and Medicine, 50 (5) pp. 617-623. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6475FF0DFDFE]

La recherche en neurosciences : "on est fait pour s'entendre" ou comment neurosciences et psychiatrie se sont rentonctrées au Département de psychiatrie

Magistretti Pierre, 2011. pp. 234-236 dans Guex Patrice, Gasser Jacques (eds.) Pour une psychiatrie scientifique et humaniste chap. 16, Georg.

[serval:BIB_D739C8042483]

Monographs on drugs which are frequently analyzed in therapeutic drug monitoring/Arzneimittel-Monographien für Medikamente, die regelmäßig im Rahmen des Therapeutic Drug Monitorings analysiert werden

Rentsch Katharina, Buhl Daniela, Eap Chin Bin, Fathi Marc, Thormann Wolfgang, Werner Dominique, 2011/01. LaboratoriumsMedizin, 35 (2) pp. 81-91. Peer-reviewed.

[URN][DOI][WoS][serval:BIB_18B42DC0B70C]

Multimorbidität und Polypharmazie in der Psychiatrie

Baumann Pierre, Greil Waldemar, 2011. pp. 58-59 dans 9. SGAMSP-Jahrestagung, InFo Neurologie und Psychiatrie.

[serval:BIB_3B7A8B6998BC]

Oxidative stress and schizophrenia: 1H-MRS at 14.1 T in developing mice with glutathione deficit

Do Kim Q, Duarte J.M., Kulak A., Cuenod M., Gruetter R., 2011. p. 123 dans 13th International Congress on Schizophrenia Research (ICOSR), Schizophrenia Bulletin. Peer-reviewed.

[WoS][serval:BIB_88B64831EC0E]

Oxidative stress during development in prefrontal cortical interneurons in developmental animal models of schizophrenia

O'Donnell ., Cabungcal H.J., Piantadosi P., Lewis E., Calhoon G.G., Do K., 2011. p. 111 dans 13th International Congress on Schizophrenia Research (ICSR), Schizophrenia Bulletin. Peer-reviewed.

[WoS][serval:BIB_B74A1E1B6E53]

Oxytocin selectively gates fear responses through distinct outputs from the central amygdala.

Viviani D., Charlet A., van den Burg E., Robinet C., Hurni N., Abatis M., Magara F., Stoop R., 2011. Science, 333 (6038) pp. 104-107. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_63636CF05C9E]

Pharmacogenetic study on metabolic syndrome induced by atypical antipsychotics and mood stabilizers.

Choong E, Bondolfi G, Eap C, Oneda B, Etter M, 2011/01/01. dans 31st Annual meeting of Swiss Society of Biological Psychiatry, January 2011, Lausanne, Switzerland..

[serval:BIB_3E507D03509E]

Pharmacokinetics of psychotropic drugs - keys for treatments' improvements

Baumann Pierre, 2011. p. 1995 dans 19th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[serval:BIB_ACC0E2992744]

Psychiatrie [Psychiatry].

Guex P., Conus P., Pomini V., Kramer U., Bonsack C., Eap C., 2011. Revue Médicale Suisse, 7 (278) pp. 150-153. Peer-reviewed.

[Pmid][serval:BIB_EB85B71B9C22]

Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoring.

Choong E., Rudaz S., Kottelat A., Haldemann S., Guillarme D., Veuthey J.L., Eap C.B., 2011. Journal of Chromatography. B, 879 (19) pp. 1544-1550. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5BEFDB40A967]

Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation.

Dobrinas M., Choong E., Noetzli M., Cornuz J., Ansermot N., Eap C.B., 2011. Journal of Chromatography. B, Analytical Technologies In the Biomedical and Life Sciences, 879 (30) pp. 3574-3582. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_36445F679F00]

Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.

Holzer L., Preuss U., Baumgartner L., Jaugey L., Urben S., Halfon O., Baumann P., 2011. Pharmacopsychiatry, 44 (3) pp. 87-95. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0006FD7FBE51]

Redox dysregulation and oxidative stress affects parvalbumin interneurons and neural synchrony in anterior cingulate cortex during neurodevelopment

Cuenod M., Cabungcal J.H., Kulak A., Steullet P., Do K., 2011. p. 102 dans 13th International Congress on Schizophrenia Research (ICSR), Schizophrenia Bulletin. Peer-reviewed.

[WoS][serval:BIB_FED35CE3306F]

Redox dysregulation in early psychosis and relevant animal models

Do Kim Q., Cabungcal J. H., Cuenod M., Kulak A., Steullet P., Conus P., 2011. p. 115 dans 13th International Congress on Schizophrenia Research (ICSR), Schizophrenia Bulletin. Peer-reviewed.

[URN][DOI][WoS][serval:BIB_1C51CE5EC94D]

Role of the glyoxalase system in astrocyte-mediated neuroprotection.

Bélanger M., Yang J., Petit J.M., Laroche T., Magistretti P.J., Allaman I., 2011. Journal of Neuroscience, 31 (50) pp. 18338-18352.

[URN][DOI][WoS][Pmid][serval:BIB_8AB2257F5A3A]

Simultaneous determination of antidementia drugs by HPLC-MS: validation data of the method and plasma level determinations in 300 patients

Noetzli M., Choong E., Ansermot N., Eap C.B., 2011. p. 501 dans 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Therapeutic Drug Monitoring. Peer-reviewed.

[WoS][serval:BIB_76D89205506F]

Simultaneous determination of antidementia drugs in human plasma for therapeutic drug monitoring.

Noetzli M., Choong E., Ansermot N., Eap C.B., 2011. Therapeutic Drug Monitoring, 33 (2) pp. 227-238. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_982CF39955B2]

Sleep deprivation induces transcriptional modifications of genes related to astrocyte-neuron lactate shuttle in astrocytes

Petit J. M., Gyger J., Fiumelli H., Martin J. L., Magistretti P., 2011. pp. S55 dans 10th European meeting on Glial Cells in Health and Disease, GLIA. Peer-reviewed.

[WoS][serval:BIB_3B77E4E98260]

Strategic Adaptation in Function of Chronicity of Schizophrenic Symptoms During A Fluency Task: An fMRI Study

Jaugey L., Urben S., Vianin P., Marquet P., Fornari E., Halfon O., Bovet P., Magistretti P., Holzer L., 2011. pp. 232S-233S dans 66th Annual Meeting of the Society of Biological Psychiatry, Biological Psychiatry. Peer-reviewed.

[WoS][serval:BIB_B96C1D53892B]

The role of matrix metalloproteinase mmp-9 in peripheral neural system regeneration

Pelsoczi P., Monin A., Nadra K., Medard J.J., Chrast R., 2011. pp. S53 dans 10th European meeting on Glial Cells in Health and Disease, GLIA. Peer-reviewed.

[WoS][serval:BIB_83944F59CE97]

The role of the ubiquitin proteasome system in Alzheimer's disease.

Riederer B.M., Leuba G., Vernay A., Riederer I.M., 2011. Experimental Biology and Medicine, 236 (3) pp. 268-276. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8D985D4B3A96]

Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scale.

Brünen S., Vincent P.D., Baumann P., Hiemke C., Havemann-Reinecke U., 2011. Therapeutic Drug Monitoring, 33 (5) pp. 561-572. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DAA099CD57B1]

Therapeutic drug monitoring in psychiatry.

Conca A., Baumann P., Hiemke C., 2011. Pharmacopsychiatry, 44 (6) pp. 193-194. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_782D63B9AEF6]

Therapeutic drug monitoring of drugs for treatment of substance-related disorders

Brünen S., Vincent P.D., Baumann P., Hiemke C., Havemann-Reinecke U., 2011. p. 13 dans 19th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_CAD92C69F48E]

Usefulness of methadone plasma concentration measurement in patients receiving nevirapine or efavirenz.

Pelet A., Favrat B., Cavassini M., Eap C.B., Besson J., Monnat M., 2011. American Journal of Drug and Alcohol Abuse, 37 (4) pp. 264-268. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_674823703779]

Vade-mecum de thérapeutique psychiatrique

Calanca Aldo (eds.), 2011., 10e éd. entièrement rév. et augm. 220, Médecine et hygiène.

[serval:BIB_95F488F0C04D]

Ventajas y desventajas del tratamiento de combinación con antipsicóticos. Reunión ECNP Consensus, marzo de 2008, Niza

Goodwin Guy, Fleischhacker Wolfgang, Arango Celso, Baumann Pierre, Davidson Michael, de Hert Marc, Falkai Peter, Kapur Shitij, Leucht Stefan, Licht Rasmus et al., 2011. Psiquiatría Biológica, 18 (2) pp. 55-67. Peer-reviewed.

[DOI][serval:BIB_8304F6454253]

Viktor von Weizsäcker et le national-socialisme : à propos de la Carte blanche du Pr Marco Vannotti : pathosophie ou l'objet de la médecine

Baumann Pierre, 2011. Revue médicale suisse 333 p. 655.

[serval:BIB_54528420E1C9]

Émergence du moi cérébral de Theodor Meynert à Antonio Damasio = Emergence of the cerebral self, from Theodor Meynert to Antonio Damasio

Arminjon M., Ansermet F., Magistretti P., 2011. Psn-Psychiatrie Sciences Humaines Neurosciences, 9 (3) pp. 153-161. Peer-reviewed.

[DOI][WoS][serval:BIB_8B304B93EC2F]

β-Arrestin2 influences the response to methadone in opioid-dependent patients.

Oneda B., Crettol S., Bochud M., Besson J., Croquette-Krokar M., Hämmig R., Monnat M., Preisig M., Eap C.B., 2011. Pharmacogenomics Journal, 11 (4) pp. 258-266. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_02BE3E233F45]

2010

Label-free second-harmonic phase imaging of biological specimen by digital holographic microscopy.

Shaffer E., Moratal C., Magistretti P., Marquet P., Depeursinge C., 2010/12/15. Optics letters, 35 (24) pp. 4102-4104. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C3BC8F1EFDCA]

Does Methadone Prolong QTc Intervals by Depleting Testosterone Levels?—Reply

Ansermot Nicolas, Albayrak Oezguer, Schlaepfer Juerg, Wavre Crettol Séverine, Croquette-Krokar Marina, Bourquin Michel, Deglon J.J., Faouzi M., Rey F., Scherbaum N. et al., 2010/08/09. Archives of Internal Medicine, 170 (15) p. 1407. Peer-reviewed.

[DOI][WoS][serval:BIB_C13BF53FCF4F]

French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs.

Rougemont M., Ulrich S., Hiemke C., Corruble E., Baumann P., 2010/06. Fundamental & clinical pharmacology, 24 (3) pp. 377-384. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DBA70501F744]

Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc interval.

Ansermot N., Albayrak O., Schläpfer J., Crettol S., Croquette-Krokar M., Bourquin M., Déglon J.J., Faouzi M., Scherbaum N., Eap C.B., 2010/03/22. Archives of internal medicine, 170 (6) pp. 529-536. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2447D2DCD9A6]

Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability.

Allaman I., Gavillet M., Bélanger M., Laroche T., Viertl D., Lashuel H.A., Magistretti P.J., 2010/03/03. The Journal of neuroscience, 30 (9) pp. 3326-3338. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_D1311F834070]

A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.

Burghaus S., Hölsken A., Buchfelder M., Fahlbusch R., Riederer B.M., Hans V., Blümcke I., Buslei R., 2010/03. Virchows Archiv, 456 (3) pp. 287-300. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6A9A91CF89CE]

A la rencontre de Pierre Magistretti

Magistretti Pierre, Parizot Suzanne (interviewer), Conus Philippe (interviewer), 2010. Information psychiatrique, 86 (6) pp. 529-532.

[serval:BIB_ACAF7749FC5D]

Association study of 182 candidate genes in anorexia nervosa.

Pinheiro A.P., Bulik C.M., Thornton L.M., Sullivan P.F., Root T.L., Bloss C.S., Berrettini W.H., Schork N.J., Kaye W.H., Bergen A.W. et al., 2010. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 153B (5) pp. 1070-1080. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_6B19414F0835]

Attenuated asymmetry of functional connectivity in schizophrenia: a high-resolution EEG study.

Jalili M., Meuli R., Do K.Q., Hasler M., Crow T.J., Knyazeva M.G., 2010. Psychophysiology, 47 (4) pp. 706-716. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8A2CAD0AEC32]

Burnout: eine Standortbestimmung

Nil Rico, Jacobshagen Nicola, Schächinger Hartmut, Baumann Pierre, Höck Paul, Hättenschwiler Josef, Ramseier Fritz, Seifritz Erich, Holsboer-Trachsler Edith, 2010. Schweizer Archiv für Neurologie und Psychiatrie = Archives Suisses de Neurologie et de Psychiatrie = Archivio Svizzero Di Neurologia E Psichiatria, 161 (2) pp. 72-77. Peer-reviewed.

[serval:BIB_3481C1A99F4A]

Cell morphology and intracellular ionic homeostasis explored with a multimodal approach combining epifluorescence and digital holographic microscopy.

Pavillon N., Benke A., Boss D., Moratal C., Kühn J., Jourdain P., Depeursinge C., Magistretti P.J., Marquet P., 2010. Journal of Biophotonics, 3 (7) pp. 432-436. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B6AFEA5BE1AB]

Comment on recent modeling studies of astrocyte-neuron metabolic interactions.

Jolivet R., Allaman I., Pellerin L., Magistretti P.J., Weber B., 2010. Journal of Cerebral Blood Flow and Metabolism, 30 (12) pp. 1982-1986.

[DOI][WoS][Pmid][serval:BIB_7D4305961163]

De l'eau et des neurones... IRM de diffusion, cartographie cérébrale et brèves perspectives psychiatriques

Baumann P.S., Hagmann P., Marquet P., Conus P., 2010. Information Psychiatrique, 86 (6) pp. 493-504.

[serval:BIB_106FAADBB8A1]

Digital holographic reflectometry

Colomb Tristan, Krivec Stefan, Hutter Herbert, Akatay Ahmet Ata, Pavillon Nicolas, Montfort Frederic, Cuche Etienne, Kuehn Jonas, Depeursinge Christian, Emery Yves, 2010. Optics Express, 18 (4) pp. 3719-3731. Peer-reviewed.

[WoS][serval:BIB_28507C9A5AAD]

Evidence-based medicine for pharmacogenetics

Rossier Michel F., Rebsamen Michaela, Crettol Severine, Eap Chin B., Rentsch Katharina, 2010. Pipette : Swiss Loboratory Medicine 4 pp. 13-15.

[serval:BIB_3432451F8CA0]

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety.

Samer C.F., Daali Y., Wagner M., Hopfgartner G., Eap C.B., Rebsamen M.C., Rossier M.F., Hochstrasser D., Dayer P., Desmeules J.A., 2010. British Journal of Pharmacology, 160 (4) pp. 919-930. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B46F8324E084]

Glutathione Precursor, N-Acetyl-Cysteine, Modulates EEG Synchronization in Schizophrenia Patients

Carmeli Cristian, Knyazeva Maria G., Cuenod Michel, Do Kim Q., 2010. pp. 263S-264S dans 65th Annual Convention of the Society of Biological Psychiatry, Biological Psychiatry. Peer-reviewed.

[WoS][serval:BIB_455F49E0E3EE]

Glycogen metabolism as a marker of astrocyte differentiation.

Brunet J.F., Allaman I., Magistretti P.J., Pellerin L., 2010. Journal of Cerebral Blood Flow and Metabolism, 30 (1) pp. 51-55.

[DOI][WoS][Pmid][serval:BIB_AB802DD8EA6C]

Increased eeg synchronization in schizophrenia patients by the glutathione precursor, n-acetyl-cysteine

Carmeli Cristian, Knyazeva Maria G., Cuenod Michel, Do Kim Q., 2010. pp. 245-246 dans 2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Schizophrenia Research. Peer-reviewed.

[DOI][WoS][serval:BIB_C71B8512136B]

Introduction aux réseaux neuronaux : de la synapse à la psyché

Savioz Armand, Leuba Geneviève, Vallet Philippe G., Walzer Claude, 2010. Neurosciences et cognition 250, De Boeck.

[serval:BIB_47C69B318889]

JULIDE: a software tool for 3D reconstruction and statistical analysis of autoradiographic mouse brain sections.

Ribes D., Parafita J., Charrier R., Magara F., Magistretti P.J., Thiran J.P., 2010. Plos One, 5 (11) pp. e14094. Peer-reviewed.

[DOI][Pmid][serval:BIB_46E0FF1EDB65]

Lack of Association Between Genetic Polymorphisms of ARRB2 and Alcohol Dependence in a Caucasian Population.

Oneda B., Preisig M., Dobrinas M., Eap C.B., 2010. Alcohol and Alcoholism, 45 (6) pp. 590-591. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_54F1D1AB807E]

Les énigmes du plaisir

Ansermet François, Magistretti Pierre, 2010. 239, O. Jacob.

[serval:BIB_8399832E9928]

Metabolic alterations in the cortex of a mouse model with glutathione deficit - relevance to schizophrenia

Duarte Joao M. N., Kulak Anita, Gruetter Rolf, Do Kim Q., 2010. p. 201 dans 2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Schizophrenia Research. Peer-reviewed.

[DOI][WoS][serval:BIB_E67F0019D9B7]

Monographs on drugs which are frequently analyzed in therapeutic drug monitoring = Arzneimittel-Monographien für Medikamente, die regelmäßig im Rahmen des Therapeutic Drug Monitorings analysiert werden

Rentsch K., Buhl D., Eap C.B., Fathi M., Jöchle W., Magnin J.L., Thormann W., Werner D., 2010. Laboratoriums-Medizin = Journal of Laboratory Medicine, 34 (3) pp. 129-139. Peer-reviewed.

[DOI][WoS][serval:BIB_9BD785D565D9]

Neurochemical profile of the developing mouse cortex determined by in vivo 1H NMR spectroscopy at 14.1 T and the effect of recurrent anaesthesia.

Kulak A., Duarte J.M., Do K.Q., Gruetter R., 2010. Journal of Neurochemistry, 115 (6) pp. 1466-1477. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2F325188C74D]

Neurosciences et psychanalyse : une rencontre autour de la singularité

Magistretti Pierre, Ansermet François (eds.), 2010. Collège de France 326, O. Jacob.

[serval:BIB_F0835B71EFC7]

New therapies targeting antioxidant defense and membrane integrity in schizophrenia: a prevention perspective

Lavoie Suzie, Amminger Paul, Berk Michael, Do Kim, McGorry Pat, 2010. pp. A19 dans 11th Australasian Schizophrenia Conference, Australian and New Zealand Journal of Psychiatry. Peer-reviewed.

[URN][serval:BIB_65D4B798A880]

Oxytocin enhances the inhibitory effects of diazepam in the rat central medial amygdala.

Viviani D., Terrettaz T., Magara F., Stoop R., 2010. Neuropharmacology, 58 (1) pp. 62-8. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_15B3CEC05C5F]

Pharmacogenetic study on metabolic syndrome induced by atypical antipsychotics and mood stabilizers

Choong Eva, Eap C, 2010. pp. s214 dans European Neuropsychopharmacology.

[DOI][WoS][serval:BIB_71536CB58E69]

Pharmakogenetik

Baumann Pierre, 2010. pp. 337-351 dans Riederer Peter F., Laux Gerd (eds.) Grundlagen der Neuro-Psychopharmakologie : ein Therapiehandbuch, Springer.

[URN][serval:BIB_41EFC134766D]

Pharmakokinetik. Allgemeine Grundlagen

Müller Walter E., Hiemke Christoph, Baumann Pierre, 2010. pp. 289-303 dans Riederer Peter F., Laux Gerd (eds.) Grundlagen der Neuro-Psychopharmakologie : ein Therapiehandbuch, Springer.

[URN][serval:BIB_38756A51423B]

Plasticité et homéostasie à l'interface entre neurosciences et psychanalyse

Magistretti Pierre, Ansermet François, 2010. pp. 17-28 dans Magistretti Pierre, Ansermet François (eds.) Neurosciences et psychanalyse : une rencontre autour de la singularité, O. Jacob.

[serval:BIB_1311D897A6CE]

Professeur Alfred Bader: une nécrologie

Baumann Pierre, 2010. Schweizer Archiv für Neurologie und Psychiatrie = Archives Suisses de Neurologie et de Psychiatrie = Archivio Svizzero Di Neurologia E Psichiatria, 161 (1) pp. 46-47. Peer-reviewed.

[serval:BIB_839BA85D323D]

Prospective assessment of CYP2D6 by genotyping, phenotyping and measurement of tamoxifen, PD 05-09 4-hydroxy-tamoxifen and endoxifen in breast cancer patients treated with tamoxifen.

Zaman K., Dahmane E., Perey L., Buclin T., Berthod G., Bodmer A., Galmiche M., Leyvraz S., Eap C., Csajka C. et al., 2010. dans 33rd Annual San Antonio Breast Cancer Symposium.

[URN][serval:BIB_34EABEDF4890]

Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with l- and d,l-methadone.

Wedekind D., Jacobs S., Karg I., Luedecke C., Schneider U., Cimander K., Baumann P., Ruether E., Poser W., Havemann-Reinecke U., 2010. World Journal of Biological Psychiatry, 11 (2 Pt 2) pp. 390-399. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0871D0C2BA49]

Quel inconscient ?

Ansermet François, Margistretti Pierre, 2010. pp. 195-200 dans Magistretti Pierre, Ansermet François (eds.) Neurosciences et psychanalyse : une rencontre autour de la singularité, O. Jacob.

[serval:BIB_BB3B77854477]

Quel rôle pour les neurosciences dans l'amélioration du traitement de la phase précoce des troubles psychotiques ?: exemple de l'hypothèse de la dysrégulation glutathion/redox dans la schizophrénie

Conus Philippe, Do Kim Q., 2010. Information psychiatrique, 86 (6) pp. 484-492.

[serval:BIB_B1E9B0688F9D]

Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.

Nikisch G., Baumann P., Wiedemann G., Kiessling B., Weisser H., Hertel A., Yoshitake T., Kehr J., Mathé A.A., 2010. Journal of Clinical Psychopharmacology, 30 (5) pp. 496-503. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7CD21C4AC442]

Recent Progress and Perspectives in Digital Holographic Microscopy

Marquet P., Jourdain P., Boss D., Depeursinge C., Magistretti P., 2010. p. 012024 dans 8th International Workshop on Information Optics, Journal of Physics Conference Series.

[DOI][serval:BIB_2F87F3871AAE]

Redox dysregulation affects parvalbumine interneuron's integrity and neural synchronisation in ventral but not dorsal hippocampus

Cabungcal Jan-Harry, Steullet Pascal, Frank Anita, Kraftsik Rudolf, Ying Chen, Dalton Timothy P., Cuenod Michel, Do Kim Q., 2010. p. 388 dans 2nd Biennial Schizophrenia International Research Conference, Schizophrenia Research. Peer-reviewed.

[DOI][serval:BIB_E3804CDF2BBF]

Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors.

Steullet P., Cabungcal J.H., Kulak A., Kraftsik R., Chen Y., Dalton T.P., Cuenod M., Do K.Q., 2010. Journal of Neuroscience, 30 (7) pp. 2547-2558. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_E711ECBB2BA9]

Redox dysregulation and oxidative stress in schizophrenia: nutrigenetics as a challenge in psychiatric disease prevention.

Do K.Q., Conus P., Cuenod M., 2010. World Review of Nutrition and Dietetics, 101 pp. 131-153. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4672EE672A60]

Redox dysregulation and oxidative stress in schizophrenia: nutrigenetics as a challenge in psychiatric disease prevention.

Do K.Q., Conus P., Cuenod M., 2010. Journal of Nutrigenetics and Nutrigenomics, 3 (4-6) pp. 267-289. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0C44D123CD17]

Regulation of dendritic development by BDNF requires activation of CRTC1 by glutamate.

Finsterwald C., Fiumelli H., Cardinaux J.R., Martin J.L., 2010. Journal of Biological Chemistry, 285 (37) pp. 28587-28595. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_3AD7B542B615]

Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.

Nikisch G., Baumann P., Kiessling B., Reinert M., Wiedemann G., Kehr J., Mathé A.A., Piel M., Roesch F., Weisser H. et al., 2010. Journal of Psychiatric Research, 44 (12) pp. 754-759. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_473AC24F4018]

SPCCtdm, a Catalogue for analysis of Therapeutic drug Monitoring related Contents in the drug Prescription Information

Ulrich Sven, Baumann Pierre, Conca Andreas, Kuss Hans-Joachim, Stieffenhofer Viktoria, Hiemke Christoph, 2010. International Journal of Knowledge Discovery in Bioinformatics, 1 (2) pp. 1-11. Peer-reviewed.

[serval:BIB_DB52A2FAF903]

Spezielle Pharmakokinetik

Müller Walter E., Hiemke Christoph, Baumann Pierre, 2010. pp. 305-312 dans Riederer Peter F., Laux Gerd (eds.) Grundlagen der Neuro-Psychopharmakologie : ein Therapiehandbuch, Springer.

[URN][serval:BIB_C6C8895567AA]

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone.

[DOI][WoS][Pmid][serval:BIB_455E2ECC59E1]

The homeostatic psyche: Freudian theory and somatic markers.

Arminjon M., Ansermet F., Magistretti P., 2010. Journal of Physiology, Paris, 104 (5) pp. 272-278. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DEF72D1F4FAD]

The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution.

Choong E., Dobrinas M., Carrupt P.A., Eap C.B., 2010. Expert Opinion On Drug Metabolism and Toxicology, 6 (8) pp. 953-965. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B9CC1CA46639]

Therapeutic Drug Monitoring

Baumann Pierre, 2010. pp. 1307-1313 dans Stolerman Ian P. (eds.) Encyclopedia of Psychopharmacology, Springer.

[serval:BIB_3A645548793B]

Trace, représentation et homéostasie

Armingon Mathieu, Ansermet François, Magistretti Pierre, 2010. pp. 83-102 dans Magistretti Pierre, Ansermet François (eds.) Neurosciences et psychanalyse : une rencontre autour de la singularité, O. Jacob.

[serval:BIB_B9E53430DDA1]

Water movements associated with neuronal activity revealed by optical methods: Focus on digital holographic microscopy

Marquet Pierre, Jourdain pascal, Depeursinge Christian, Magistretti Pierre, 2010/01/01. dans Water: The Forgotten Biological Molecule, Pan Stanford Publishing Pte. Ltd.

[serval:BIB_93DDC5065039]

2009

High throughput sequencing and proteomics to identify immunogenic proteins of a new pathogen: the dirty genome approach.

Greub G., Kebbi-Beghdadi C., Bertelli C., Collyn F., Riederer B.M., Yersin C., Croxatto A., Raoult D., 2009/12/23. PloS one, 4 (12) pp. e8423. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_23EB15A4F7BE]

The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test.

Oneda B., Crettol S., Jaquenoud Sirot E., Bochud M., Ansermot N., Eap C.B., 2009/11. Pharmacogenetics and genomics, 19 (11) pp. 877-883. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_078310C1D51D]

From care to cure.

Riederer B.M., Leuba G., 2009/10. Brain research bulletin, 80 (4-5) pp. 171-172. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_12649EB29314]

Mouse fertility is not dependent on the CREB coactivator Crtc1.

Breuillaud L., Halfon O., Magistretti P.J., Pralong F.P., Cardinaux J.R., 2009/09. Nature medicine, 15 (9) pp. 989-90. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_EB08AC18BF5C]

Tamoxifen metabolism and the impact of Tamoxifen dose on the level of the active metabolites in endocrine sensitive breast cancer patients

Dahmane Elyes, Csajka Chantal, Decosterd Laurent, Mercier Thomas, Zanolari Boris, Eap Chin, Buclin Thierry, Galmiche Marie, Zaman Khalil, 2009/09. dans ''Frontiers in drug discovery and development'' : 24ème séminaire, 3ème cycle, en sciences pharmaceutiques.

[URN][serval:BIB_646DE6013BB6]

ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.

Jaquenoud Sirot E., Knezevic B., Morena G.P., Harenberg S., Oneda B., Crettol S., Ansermot N., Baumann P., Eap C.B., 2009/08. Journal of clinical psychopharmacology, 29 (4) pp. 319-326. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0F54C2F3BEB3]

Skin fibroblast model to study an impaired glutathione synthesis: consequences of a genetic polymorphism on the proteome.

Gysin R., Riederer I.M., Cuénod M., Do K.Q., Riederer B.M., 2009/04/06. Brain research bulletin, 79 (1) pp. 46-52. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7BAA49DEE938]

A developmental in vivo 1H NMR study in mice with genetic redox dysregulation: an animal model with relevance to schizophrenia

Frank A., Duarte J.M., Do K.Q., Gruetter R., 2009. p. 97 dans 22nd Biennial Meeting of the International-Society-of-Neurochemistry/Asian-Pacific-Society-for-Neurochemistry, Busan, South Korea, August 23-29, 2009, Journal of Neurochemistry. Peer-reviewed.

[DOI][serval:BIB_67FF1F5ECAE4]

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

Goodwin G., Fleischhacker W., Arango C., Baumann P., Davidson M., de Hert M., Falkai P., Kapur S., Leucht S., Licht R. et al., 2009. European Neuropsychopharmacology, 19 (7) pp. 520-532. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8EF223FB046E]

Alteration of brain glycogen turnover in the conscious rat after 5h of prolonged wakefulness.

Morgenthaler F.D., Lanz B.R., Petit J.M., Frenkel H., Magistretti P.J., Gruetter R., 2009. Neurochemistry International, 55 (1-3) pp. 45-51. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_16A811008BD8]

Aspects génétiques de la consommation de tabac et prise en charge clinique [Genetic aspects of smoking and impact on clinical care]

Dobrinas M., Cornuz J., Kohler Serra M., Puhl M., Eap C.B., 2009. Revue médicale suisse, 5 (210) pp. 1463-7. Peer-reviewed.

[Pmid][serval:BIB_0E76F96A505E]

Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study.

Hallinan R., Crettol S., Agho K., Attia J., Besson J., Croquette-Krokar M., Hämmig R., Déglon J.J., Byrne A., Ray J. et al., 2009. European Journal of Clinical Pharmacology, 65 (11) pp. 1113-1120.

[URN][DOI][WoS][Pmid][serval:BIB_879A09F2BE27]

Cardiac left bundle branch block and pancytopenia in anorexia nervosa: higher risk with mirtazapine and pantoprazole? Case report.

Walder A., Baumann P., 2009. Pharmacopsychiatry, 42 (2) pp. 79-81. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_1B86426D8013]

Cognitive remediation in schizophrenia

Jaugey L., Vianin P., Marquet P., Magistretti P., Bovet P., Holzer E., Meuli R., Fornari E., 2009. dans CIBM-CHUV MR Research Meeting.

[serval:BIB_82286B1D4522]

Contribution of neural networks to Alzheimer disease's progression.

Savioz A., Leuba G., Vallet P.G., Walzer C., 2009. Brain Research Bulletin, 80 (4-5) pp. 309-314. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F15FCFD1D639]

Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit.

Lavoie S., Chen Y., Dalton T.P., Gysin R., Cuénod M., Steullet P., Do K.Q., 2009. Journal of Neurochemistry, 108 (6) pp. 1410-1422. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_89D1C678ED98]

CYP3A5 and ABCB1 genes and hypertension.

Bochud M., Bovet P., Burnier M., Eap C.B., 2009. Pharmacogenomics, 10 (3) pp. 477-487. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4D26D0016704]

Deciphering neuron-glia compartmentalization in cortical energy metabolism.

Jolivet R., Magistretti P.J., Weber B., 2009. Frontiers In Neuroenergetics, 1 p. 4. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_EE6DC6DB2D73]

Decreased behavioral impairments in an Alzheimer mice model by interfering with TNF-alpha metabolism.

Giuliani F., Vernay A., Leuba G., Schenk F., 2009. Brain Research Bulletin, 80 (4-5) pp. 302-308. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_BB66C769237B]

Detection of glutathione with high precision in the anterior cingulate using short TE 1H MRS at 3T

Meckle R., Gambarotta G., Teichmann T., Chevrey N., Browaeys P., Meuli R., Michel C., Do K., Cuenod M., Gruetter R., 2009. dans CIBM-CHUV MR Research Meeting.

[serval:BIB_6F9D04A224C0]

Developmental critical period in genetic redox dysregulation: animal and human studies in schizophrenia

Do Kim Q., Conus P., Bovet P., Cabungcal J.H., Frank A., Gysin R., Lavoie S., Polari A., Steullet P., Teichmann T. et al., 2009. pp. 106-107 dans Schizophrenia Bulletin, Schizophrenia Bulletin. Peer-reviewed.

[DOI][serval:BIB_FB90AC9C35F8]

Developmental critical period in gentic redox dysregulation: animal and human studies in schizophrenia

Do Kim Q., Conus P., Bovet P., Cabungcal J.H., Frank A., Gysin R., Lavoie S., Polari A., Steullet P., Teichmann T. et al., 2009. pp. 106-107 dans 12th International Congress on Schizophrenia Research, San Diego, CA, March 28-April 01, 2009, Schizophrenia Bulletin. Peer-reviewed.

[DOI][serval:BIB_122CB7465023]

Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.

Leuba G., Vernay A., Zimmermann V., Saini K., Kraftsik R., Savioz A., 2009. Brain Research Bulletin, 80 (4-5) pp. 196-202. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_52501D0D1FAE]

Drug-induced Pisa syndrome under quetiapine.

Walder A., Greil W., Baumann P., 2009. Progress in neuro-psychopharmacology & biological psychiatry, 33 (7) pp. 1286-7. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8C63681B5E08]

Early glutathione deficit impairs parvalbumin expression in gaba interneurons and kainate-induced gamma oscillations

Cabungcal J.H., Steullet P., Frank A., Chen Y., Cuenod M., Do K.Q., 2009. pp. 136-137 dans 12th International Congress on Schizophrenia Research, San Diego, CA, March 28-April 01, 2009, Schizophrenia Bulletin. Peer-reviewed.

[DOI][serval:BIB_E17B1667EB62]

General unknown screening procedure for the characterization of human drug metabolites: application to loratadine phase I metabolism.

Picard N., Dridi D., Sauvage F.L., Boughattas N.A., Marquet P., 2009. Journal of separation science, 32 (13) pp. 2209-17. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C13247A9E144]

Genetic redox dysregulation induces behavioural deficits in the adult mouse: an animal model for schizophrenia

Frank A., Dalton T., Chen Y., Cuenod M., Do K.Q., 2009. p. 61 dans Annual Conference of the Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) and the Swiss Society of Biological Psychiatry (SSBP), Bern, March 25 and 26, 2009, Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_4D7A35E417E8]

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function.

di Iulio J., Fayet A., Arab-Alameddine M., Rotger M., Lubomirov R., Cavassini M., Furrer H., Günthard H.F., Colombo S., Csajka C. et al., 2009. Pharmacogenetics and Genomics, 19 (4) pp. 300-309. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_69748BF486BC]

La prescription off label dans le cadre des troubles bipolaires soulève des questions en pratique clinique

Baumann Pierre, 2009. PSY and PSY.

[serval:BIB_2B1DE9AF44E0]

Monographs on drugs which are frequently analyzed in therapeutic drug monitoring

Rentsch K., Eap C.B., Fathi M., Grignaschi N., Magnin J.L., Thormann W., Todesco L., Werner D., 2009. Journal of Laboratory and Clinical Medicine, 33 (2) pp. 99-120.

[URN][DOI][WoS][serval:BIB_B010C144075A]

Mood stabilizer therapy and pravastatin: higher risk for adverse skin reactions ?

Walder alice, Baumann Pierre, 2009. Acta Medica (Hradec Kralove), 52 (1) pp. 15-18. Peer-reviewed.

[serval:BIB_AAC25B70403A]

Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia.

Butticaz C., Werge T., Beckmann J.S., Cuénod M., Do K.Q., Rivolta C., 2009. Psychiatric genetics, 19 (4) pp. 201-8. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_08D720EF4F22]

Nachruf : Prof. Alfred Bader = Nécrologie : Professeur Alfred Bader

Baumann Pierre, 2009. Psy and Psy 2 p. 22.

[serval:BIB_DCE0573363EA]

Neuroprotective role of lactate after cerebral ischemia.

Berthet C., Lei H., Thevenet J., Gruetter R., Magistretti P.J., Hirt L., 2009. Journal of Cerebral Blood Flow and Metabolism, 29 (11) pp. 1780-1789. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_35DC3E05F74D]

Neuroscience. Low-cost travel in neurons.

Magistretti P.J., 2009. Science, 325 (5946) pp. 1349-1351.

[DOI][WoS][Pmid][serval:BIB_F4C45363A80D]

Noninvasive characterization of the fission yeast cell cycle by monitoring dry mass with digital holographic microscopy.

Rappaz B., Cano E., Colomb T., Kühn J., Depeursinge C., Simanis V., Magistretti P.J., Marquet P., 2009. Journal of biomedical optics, 14 (3) p. 034049. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8258ED09645A]

Oxidation proteomics: the role of thiol modifications

Riederer B.M, 2009. Current Proteomics, 6 (1) pp. 51-62.

[WoS][serval:BIB_F23E1D0CEB06]

Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals.

Arab-Alameddine M., Di Iulio J., Buclin T., Rotger M., Lubomirov R., Cavassini M., Fayet A., Décosterd L.A., Eap C.B., Biollaz J. et al., 2009. Clinical Pharmacology and Therapeutics, 85 (5) pp. 485-494. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_09C3908EC60D]

Plasticité neuronale et inconscient

Ansermet François, Magistretti Pierre, 2009. pp. 201-211 dans Ouss Lisa (eds.) Vers une neuropsychanalyse ?, O. Jacob.

[serval:BIB_ABFF359BA2A0]

Polymedication in elderly psychiatric patients suffering from comorbidities: risks for pharmacokinetic interactions with clinical consequences

Baumann Pierre, 2009/01., 17th European congress of psychiatry, January 24-28, 2009, Lisbon, Portugal pp. S48-03 dans , European psychiatry. Peer-reviewed.

[serval:BIB_A6FCDB0D8658]

Prescription off-label et troubles bipolaires: questions en pratique clinique

Baumann Pierre, 2009. Psy & Psy 2 pp. 10-11.

[serval:BIB_762F7B4D8F21]

Prevention of age-associated dementia.

Mohajeri M.H., Leuba G., 2009. Brain Research Bulletin, 80 (4-5) pp. 315-325. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7CA481DB1BE8]

Psychopharmaka - Off-Label-Use (1/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 22 pp. 4-7.

[serval:BIB_B2406D9B6FCB]

Psychopharmaka - Off-Label-Use (2/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 23 pp. 4-6.

[serval:BIB_B7EF4445F9F5]

Red blood cell structure and dynamics explored with digital holographic microspcopy

Marquet P., Rappaz B., Barbuld A., Korensteind R., Depeursinge C., Magistretti P., 2009. Progress in Biomedical Optics and Imaging, 7182 pp. 71821A. Peer-reviewed.

[DOI][WoS][serval:BIB_2B585D793299]

Redox dysregulation in schizophrenia: Genetic susceptibility and pathophysiological mechanisms, Handbook of neurochemistry and molecular neurobiology

Do KQ, Bovet P, Cabungcal JH, Conus P, Gysin R, Lavoie S, Steullet P, Cuenod M, 2009. pp. 286-311 dans Lajtha Abel (eds.) Handbook of neurochemistry and molecular neurobiology, Springer Science+Business Media.

[serval:BIB_C1EE2BF77328]

Redox dysregulation, neurodevelopment, and schizophrenia.

Do K.Q., Cabungcal J.H., Frank A., Steullet P., Cuenod M., 2009. Current opinion in neurobiology, 19 (2) pp. 220-30. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5B7B7882D993]

Role of glutamate in neuron-glia metabolic coupling.

Magistretti P.J., 2009. American Journal of Clinical Nutrition, 90 (3) pp. 875S-880S. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_CB58F139E432]

Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes.

Beeler N., Riederer B.M., Waeber G., Abderrahmani A., 2009. Brain Research Bulletin, 80 (4-5) pp. 274-281.

[DOI][WoS][Pmid][serval:BIB_ADF761435004]

Spatial analysis of erythrocyte membrane fluctuations by digital holographic microscopy.

Rappaz B., Barbul A., Hoffmann A., Boss D., Korenstein R., Depeursinge C., Magistretti P.J., Marquet P., 2009. Blood cells, molecules & diseases, 42 (3) pp. 228-32. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A92908DCE34A]

Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour

Lind Anna-Britta, Reis Margareta, Bengtsson Finn, Jonzier Perey Michèle, Powell Golay Kerry, Ahlner Johan, Baumann Pierre, Dahl Marja-Liisa, 2009. Clinical Pharmacokinetics, 48 (1) pp. 63-70. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7CFD46C09739]

Stimulation-induced increases of astrocytic oxidative metabolism in rats and humans investigated with 1-11C-acetate

Wyss M.T., Weber B., Treyer V., Heer S., Pellerin L., Magistretti P.J., Buck A., 2009. Journal of Cerebral Blood Flow and Metabolism, 29 (1) pp. 44-56. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2E72FE2379B7]

Submicrometer tomography of cells by multiple-wavelength digital holographic microscopy in reflection

Kühn J., Montfort F., Colomb T., Rappaz B., Moratal C., Pavillon N., Marquet P., Depeursinge C., 2009. Optics letters, 34 (5) pp. 653-655. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_40678CC312D4]

The role of astroglia in neuroprotection.

Bélanger M., Magistretti P.J., 2009. Dialogues In Clinical Neuroscience, 11 (3) pp. 281-295. Peer-reviewed.

[URN][Pmid][serval:BIB_485505221EB5]

Therapeutic drug monitoring and pharmacogenetic tests in pharmacovigilance - when and what ?

Jaquenoud Sirot E., Baumann P., 2009/01., 17th European congress of psychiatry, January 24-28, 2009, Lisbon, Portugal pp. S20-02 dans , European Psychiatry. Peer-reviewed.

[serval:BIB_D1F4EA0F09D6]

Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS.

Choong E., Rudaz S., Kottelat A., Guillarme D., Veuthey J.L., Eap C.B., 2009. Journal of Pharmaceutical and Biomedical Analysis, 50 (5) pp. 1000-1008. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A9702E4751B4]

Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease.

Riederer I.M., Schiffrin M., Kövari E., Bouras C., Riederer B.M., 2009. Brain Research Bulletin, 80 (4-5) pp. 233-241.

[DOI][WoS][Pmid][serval:BIB_B7DA1B4BD6DC]

Un regard sur la schizophrénie

Bertholet Léa, Do Kim Q., Schenk Françoise, Ansermot Nicolas, Eap Chin B., 2009. Actualités psychologiques 22 pp. 77-106.

[serval:BIB_3F4C90885A67]

Une maladie neurodégénérative à l'assaut de la mémoire

Leuba G., 2009. Actualités Psychologiques, 22 pp. 17-37.

[serval:BIB_BB6E7F4D2368]

Utilisation «off label» des médicaments psychotropes (1/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 22 pp. 7-10.

[URN][serval:BIB_012C292BD483]

Utilisation «off label» des médicaments psychotropes (2/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 23 pp. 8-10.

[serval:BIB_8019366AB3C9]

Validation and long-term evaluation of a modified on-line chiral analytical method for therapeutic drug monitoring of (R,S)-methadone in clinical samples.

Ansermot N., Rudaz S., Brawand-Amey M., Fleury-Souverain S., Veuthey J.L., Eap C.B., 2009. Journal of Chromatography. B, 877 (23) pp. 2301-2307. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0D3A9161914E]

2008

Comparative study of human erythrocytes by digital holographic microscopy, confocal microscopy, and impedance volume analyzer.

Rappaz B., Barbul A., Emery Y., Korenstein R., Depeursinge C., Magistretti P.J., Marquet P., 2008/10. Cytometry. Part A, 73 (10) pp. 895-903. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0E05E28FB41D]

Suivi du syndrome métabolique induit par les antipsychotiques atypiques: recommandations et perspectives pharmacogénétiques [Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives]

Choong E., Solida A., Lechaire C., Conus P., Eap C.B., 2008/09/17. Revue medicale suisse, 4 (171) pp. 1994-1996,1998-1999. Peer-reviewed.

[Pmid][serval:BIB_2191648F6C07]

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.

Gex-Fabry M., Eap C.B., Oneda B., Gervasoni N., Aubry J.M., Bondolfi G., Bertschy G., 2008/08. Therapeutic drug monitoring, 30 (4) pp. 474-482. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_466AFA1A39D5]

Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction.

Fayet A., Béguin A., de Tejada B.M., Colombo S., Cavassini M., Gerber S., Eap C.B., Telenti A., Buclin T., Biollaz J. et al., 2008/08. Therapeutic drug monitoring, 30 (4) pp. 511-522. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_14181C037D30]

Serial protein labeling with infrared maleimide dyes to identify cysteine modifications

Riederer I. M., Herrero R. M., Leuba G., Riederer B. M., 2008/05. Journal of Proteomics, 71 (2) pp. 222-230. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8B018A9916E4]

Non-invasive dry mass determination and monitoring at the single cell level with digital holographic microscopy

Rappaz Benjamin, Cano Elena, Kühn Jonas, Colomb Tristan, Depeursinge Christian, Magistretti Pierre J., Marquet Pierre, 2008/04/25. Biophotonics: Photonic Solutions for Better Health Care, 6991 p. 699111. Peer-reviewed.

[DOI][WoS][serval:BIB_39BA3F4B5C37]

Simultaneous cell morphometry and refractive index measurement with dual-wavelength digital holographic microscopy and dye-enhanced dispersion of perfusion medium.

Rappaz B., Charrière F., Depeursinge C., Magistretti P.J., Marquet P., 2008/04/01. Optics letters, 33 (7) pp. 744-746. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_185FC1BBEB1E]

Dysfonctions sexuelles induites par les antidépresseurs et les antipsychotiques et leurs traitements [Sexual dysfunctions induced by antidepressants and antipsychotics]

Martin-Du P.R., Baumann P., 2008/03/26. Revue medicale suisse, 4 (150) pp. 758-762. Peer-reviewed.

[Pmid][serval:BIB_A0273AA36C15]

Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11

Contact
Annuaires

Informations légales
Plan du site
Edition